Blood Trials

Intellicig has been at the forefront of electronic cigarette research for over 3 years.

In conducting blood trials to determine product safety, Intellicig remains a flagship for research. Intellicig employs an in-house Phlebotomist to assist in trials of this nature.

Intellicig has worked with a leading laboratory in the UK to determine the levels of nicotine delivered from the Intellicig to the user. These trials are essential as a method of ensuring the consumer is not put at risk from excessive nicotine levels.

Intellicig has conducted trials on test groups with a variety of ECOpure preparations to establish safe limits of use. Trial results have proved very promising for Intellicig, who can confidently counter claims that no nicotine is delivered to the end user.